Edition:
United States

Protalex Inc (PRTX.PK)

PRTX.PK on OTC Markets Group

1.10USD
--
Change (% chg)

-- (--)
Prev Close
$1.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,092
52-wk High
$3.00
52-wk Low
$0.31

Chart for

About

Protalex, Inc. is a clinical-stage company. The Company is focused on the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including rheumatoid arthritis (RA) and Immune Thrombocytopenia (ITP). The Company's lead product candidate, PRTX-100, is a formulation of the Staphylococc... (more)
No analyst recommendations are available for .

Overall

Beta: 1.67
Market Cap(Mil.): $31.64
Shares Outstanding(Mil.): 28.77
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.35 15.79
EPS (TTM): -- -- --
ROI: -- 15.11 12.01
ROE: -- 16.52 15.91

Earnings vs. Estimates

No consensus analysis data available.